rhamnose has been researched along with Cystic Fibrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grzegorczyk, A; Hallberg, K; Larson, G; Strandvik, B | 1 |
| Forget, PP; Hendriks, HJ; van Kreel, B | 1 |
| Döring, G; Kownatzki, R; Tümmler, B | 1 |
| Basheer, SM; Boulton, P; Ingall, CB; Penny, DJ; Walker-Smith, JA | 1 |
4 other study(ies) available for rhamnose and Cystic Fibrosis
| Article | Year |
|---|---|
Intestinal permeability in cystic fibrosis in relation to genotype.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Fatty Acids; Female; Genotype; Heterozygote; Homozygote; Humans; Intestines; Lactulose; Male; Middle Aged; Permeability; Phospholipids; Rhamnose; Xylose | 1997 |
Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Infective Agents; Biomarkers; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Inflammation; Intestinal Mucosa; Intestines; Lactulose; Lansoprazole; Longitudinal Studies; Male; Mannitol; Nitric Oxide; Omeprazole; Permeability; Rhamnose | 2001 |
Rhamnolipid of Pseudomonas aeruginosa in sputum of cystic fibrosis patients.
Topics: Chronic Disease; Cystic Fibrosis; Glycolipids; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Rhamnose; Sputum | 1987 |
Intestinal malabsorption in cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Disaccharides; Female; Humans; Intestinal Absorption; Lactulose; Malabsorption Syndromes; Male; Rhamnose | 1986 |